Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2013, Article ID 439039, 7 pages
http://dx.doi.org/10.1155/2013/439039
Research Article

Rapid Screening of Drug-Protein Binding Using High-Performance Affinity Chromatography with Columns Containing Immobilized Human Serum Albumin

1Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China
2Institute of Pharmacy, Medical School of Xiang Ya, Central South University, Changsha 410013, China
3Hepatobiliary Surgery Department, The Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, China
4Department of Pharmacy, Lushan Sanitarium of PLA, Jiujiang 332000, China

Received 25 January 2013; Accepted 28 February 2013

Academic Editor: Shuang-Qing Zhang

Copyright © 2013 Ying-Fei Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Kwon, Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism For Industrial Scientists, Kluwer Academic/Plenum Publishers, New York, NY, USA, 2001.
  2. S. L. Rodgers, A. M. Davis, N. P. Tomkinson, and H. Van De Waterbeemd, “QSAR modeling using automatically updating correction libraries: application to a human plasma protein binding model,” Journal of Chemical Information and Modeling, vol. 47, no. 6, pp. 2401–2407, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. H. van de Waterbeemd, “Which in vitro screens guide the prediction of oral absorption and volume of distribution?” Basic and Clinical Pharmacology and Toxicology, vol. 96, no. 3, pp. 162–166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. H. van de Waterbeemd, “High-throughput and in silico techniques in drug metabolism and pharmacokinetics,” Current Opinion in Drug Discovery & Development, vol. 5, no. 1, pp. 33–43, 2002. View at Google Scholar
  5. P. R. Chaturvedi, C. J. Decker, and A. Odinecs, “Prediction of pharmacokinetic properties using experimental approaches during early drug discovery,” Current Opinion in Chemical Biology, vol. 5, no. 4, pp. 452–463, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Han, C. B. Davis, and B. Wang, Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, Metabolism, Pharmaceutics, and Toxicology, John Wiley & Sons, Hoboken, NJ, USA, 2010.
  7. E. H. Kerns and L. Di, Drug-Like Properties: Concepts, Structure Design and Methods: From ADME to Toxicity Optimization, Academic Press, Amsterdam , The Netherlands, 2008.
  8. A. F. Nassar, P. F. Hollenberg, and J. Scatina, Drug Metabolism Handbook: Concepts and Applications, Wiley, Hoboken, NJ, USA, 2009.
  9. R. T. Borchardt, Optimizing the, “Drug-Like” Properties of Leads in Drug Discovery, Springer, New York, NY, USA, 2006.
  10. J. Oravcova, B. Bohs, and W. Lindner, “Drug-protein binding studies new trends in analytical and experimental methodology,” Journal of Chromatography B, vol. 677, no. 1, pp. 1–28, 1996. View at Publisher · View at Google Scholar
  11. T. A. Noctor and I. W. Wainer, “The in situ acetylation of an immobilized human serum albumin chiral stationary phase for high-performance liquid chromatography in the examination of drug-protein binding phenomena,” Pharmaceutical Research, vol. 9, no. 4, pp. 480–484, 1992. View at Publisher · View at Google Scholar
  12. P. R. Tiller, I. M. Mutton, S. J. Lane, and C. D. Bevan, “Immobilized human serum albumin: liquid chromatography/mass spectrometry as a method of determining drug-protein binding,” Rapid Communications in Mass Spectrometry, vol. 9, no. 4, pp. 261–263, 1995. View at Google Scholar · View at Scopus
  13. Y. C. Guillaume, E. Peyrin, and A. Berthelot, “Chromatographic study of magnesium and calcium binding to immobilized human serum albumin,” Journal of Chromatography B, vol. 728, no. 2, pp. 167–174, 1999. View at Publisher · View at Google Scholar
  14. M. C. Millot, S. Servagent-Noinville, N. L. Taleb, M. H. Baron, M. Revault, and B. Sébille, “Structural changes of human serum albumin immobilized on chromatographic supports: a high-performance liquid chromatography and Fourier-transform infrared spectroscopy study,” Journal of Chromatography B, vol. 753, no. 1, pp. 101–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Cheng, E. Ho, B. Subramanyam, and J. L. Tseng, “Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry,” Journal of Chromatography B, vol. 809, no. 1, pp. 67–73, 2004. View at Publisher · View at Google Scholar
  16. R. Mallik, M. J. Yoo, C. J. Briscoe, and D. S. Hage, “Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin,” Journal of Chromatography A, vol. 1217, no. 17, pp. 2796–2803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Matsuda, J. Anguizola, K. S. Joseph, and D. S. Hage, “Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin,” Journal of Chromatography A, vol. 1265, pp. 114–122, 2012. View at Publisher · View at Google Scholar
  18. Z. Tong, K. S. Joseph, and S. D. Hage, “Detection of heterogeneous drug-protein binding by frontal analysis and high-performance affinity chromatography,” Journal of Chromatography A, vol. 1218, no. 49, pp. 8915–8924, 2011. View at Publisher · View at Google Scholar
  19. R. Matsuda, J. Anguizola, K. S. Joseph, and D. S. Hage, “High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin,” Analytical and Bioanalytical Chemistry, vol. 401, no. 9, pp. 2811–2819, 2011. View at Publisher · View at Google Scholar
  20. Z. Tong, J. E. Schiel, E. Papastavros, C. M. Ohnmacht, Q. R. Smith, and D. S. Hage, “Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns,” Journal of Chromatography A, vol. 1218, no. 15, pp. 2065–2071, 2011. View at Publisher · View at Google Scholar
  21. C. Bertucci, V. Andrisano, R. Gotti, and V. Cavrini, “Use of an immobilised human serum albumin HPLC column as a probe of drug-protein interactions: the reversible binding of valproate,” Journal of Chromatography B, vol. 768, no. 1, pp. 147–155, 2002. View at Publisher · View at Google Scholar · View at Scopus